Hyponatremia Associated with Poorer Overall Survival

In metastatic renal cell cancer (mRCC) patients treated with targeted therapy, baseline hyponatremia is associated with poorer overall survival (OS), time to treatment failure (TTF), and disease control rate (DCR), according to a study published in European Urology.03/29/2014
Source: Kidney Cancer Association - Category: Cancer & Oncology Source Type: news